Cystic Fibrosis Channel
Topics & Medications
Related Channels

Tobi Podhaler Warnings and Precautions

Tobi Podhaler may cause serious complications like allergic reactions, kidney damage, or inner ear problems for some people. People who have hearing problems or kidney disease should talk to their healthcare provider before using Tobi Podhaler. Precautions and warnings should also be heeded by people who are taking certain medications and women who are pregnant or nursing.


What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to using Tobi® Podhaler™ (tobramycin inhalation powder) if you have:
  • Kidney disease, such as kidney failure (renal failure)
  • Hearing problems
  • A balance disorder or dizziness
  • A disorder that affects your muscles, such as myasthenia gravis or Parkinson's disease
  • Had an organ transplant
  • Breathing problems, such as wheezing, coughing, or chest tightness
  • Any allergies, including to foods, dyes, or preservatives.
In addition, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Specific Precautions and Warnings for Tobi Podhaler

Some warnings and precautions to be aware of prior to using Tobi Podhaler include the following:
  • Like other aminoglycoside antibiotics, this medication has been reported to cause damage to the inner ear, which could lead to hearing loss and balance problems. Let your healthcare provider know if you develop signs of inner ear damage, such as ringing in the ears, changes in hearing, dizziness, or problems with balance. Your healthcare provider may recommend tests during Tobi Podhaler treatment to monitor your hearing.
  • Aminoglycoside antibiotics may cause kidney damage, especially in people who already have kidney problems. Although this did not occur in clinical studies, Tobi Podhaler is an aminoglycoside and your healthcare provider may need to monitor how well your kidneys are working during treatment using blood and urine tests.
  • This medicine could worsen muscle weakness and should be used cautiously in people who have conditions that cause muscle weakness, such as myasthenia gravis or Parkinson's disease.
  • Tobi Podhaler can cause bronchospasms (tightening of the airways), which could lead to severe breathing problems. Let your healthcare provider know if you experience wheezing, chest tightness, coughing, or shortness of breath during treatment.
  • In clinical trials, coughing was a common side effect of Tobi Podhaler. Let your healthcare provider know if you develop an intolerable or particularly bothersome cough during treatment. He or she may be able to switch you to another medicine.
  • Tobi Podhaler is a pregnancy Category D medication. This means it may harm an unborn child if taken when pregnant (see Tobi Podhaler and Pregnancy).
  • It is unknown whether Tobi Podhaler passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to taking the drug (see Tobi Podhaler and Breastfeeding).

Tobi Inhaler Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.